The Pharma Data

OCTOBER 22, 2020

AstraZeneca’s COVID-19 vaccine candidate, AZD1222, currently being evaluated in phase 3 global trials, delivers a strong immune response, according to a new UK study. Source link.

Immune Response 52

Immune Response Vaccine Trials Research 52

The Pharma Data

DECEMBER 4, 2021

The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response. The study is funded by the Government of Canada through its COVID-19 Immunity Task Force (CITF).

Immune Response 52

Immune Response Vaccine Hospitals Laboratories 52

Science Daily: Pharmacology News

DECEMBER 13, 2023

In a study of historic scale, scientists have created an intricate map of how the immune system functions, examining the detailed molecular structures governing human T cells using the next-generation CRISPR tool known as base editing.

Immune Response 87

Immune Response Government Disease Drugs 87

SCIENMAG: Medicine & Health

JULY 6, 2023

In a new study, National Institutes of Health (NIH) researchers found that altered B cell function in children with mitochondrial disorders led to a weaker and less diverse antibody response to viral infections.

Immune Response 85

Immune Response Research 85

The Pharma Data

AUGUST 16, 2021

Better activation of innate and adaptive immune responses was achieved with CV2CoV, resulting in faster response onset, higher titers of antibodies, and stronger memory B and T cell activation as compared to the first-generation candidate, CVnCoV. “In Induction of innate immunity was investigated via specific cytokine markers.

Immune Response 52

Immune Response Vaccine Virus RNA 52

Science Daily: Pharmacology News

JULY 10, 2024

Scientists have discovered a molecular defect that promotes the pathologic immune response in systemic lupus erythematosus (known as lupus) and show that reversing this defect may potentially reverse the disease.

Immune Response 124

Immune Response Disease 124

The Pharma Data

SEPTEMBER 10, 2020

Pfizer-BioNTech announced Wednesday that preliminary preclinical data from mouse and macaque monkey models showed a strong immune response from its mRNA COVID-19 vaccine. . Photo by Md. Tareq Aziz Touhid.

Immune Response 52

Immune Response Vaccine RNA Research 52

SCIENMAG: Medicine & Health

OCTOBER 2, 2023

Osaka, Japan – Memory B cells depend on autophagy for their survival, but the protein Rubicon is thought to hinder this process. Researchers from Osaka University have discovered a shorter isoform of Rubicon called RUBCN100, which enhances autophagy in B cells.

Immune Response 52

Immune Response Research 52

Drug Discovery World

JANUARY 16, 2024

This important new study will help us to see whether giving BCG more than once stimulates a stronger immune response and whether giving it by inhalation is better than giving it into the skin. People with type 2 diabetes are more likely to get TB and part of this may be because the BCG vaccine does not work as well in this group.

Clinical Trials 147

Clinical Trials Vaccine Trials Immune Response 147

The Pharma Data

NOVEMBER 10, 2020

Canadian biopharmaceutical company Medicago has announced that its investigational COVID-19 vaccine generated “significant antibody and cellular immune responses” after two doses in all subjects in an early-stage clinical trial. The interim analysis from the phase 1 trial has been published online at the preprint server, medRxiv.

Immune Response 40

Immune Response Vaccine Clinical Trials Virus 40

Plenge Gen

APRIL 7, 2020

Here, I focus on a specific clinical inflection point in COVID-19 disease progression – hospitalized patients early in their disease course and with signs of a maladaptive immune response, with the intervention intended to prevent disease progression and admission to the ICU. appeared first on Plenge Gen @rplenge.

Immune Response 52

Immune Response Disease Clinical Trials Drugs 52

The Pharma Data

JULY 29, 2021

Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company (NYSE: LLY), and Kumquat Biosciences today announced an exclusive collaboration focused on the discovery, development and commercialization of potential novel small molecules that stimulate tumor-specific immune responses.

Small Molecule 52

Small Molecule Immune Response Research Laboratories Laboratories 52

Drug Discovery World

MAY 15, 2024

For example, the new vaccine does not include the SARS-CoV-1 coronavirus, which caused the 2003 SARS outbreak, yet it still induces an immune response to that virus. Multiple antigens are included in these chains, which trains the immune system to target specific regions shared across a broad range of coronaviruses.

Vaccine 130

Vaccine Immune Response Clinical Trials Virus 130

Drug Discovery World

MAY 2, 2024

For this study, researchers used a Covid-19 CHIM to measure what kind of immune responses stop people who have been previously infected and/or vaccinated from being infected again. The data from this COVCHIM01 study showed durable immunity post-infection/vaccination against the original Covid-19 virus.

Vaccine 147

Vaccine Immune Response Virus Treatment 147

Drug Discovery World

FEBRUARY 24, 2023

Importantly, HTI vaccines were highly immunogenic in a simpler regimen than in the previous AELIX-002 study, and the vaccine-induced responses were associated with higher time off ART, supporting the contribution of the HTI vaccines to better viral control.

Immune Response 130

Immune Response Vaccine Trials Clinical Trials 130

Drug Discovery World

APRIL 9, 2024

A study by researchers at the UCLA Health Jonsson Comprehensive Cancer Center in the US suggests that injecting engineered dendritic cells directly into cancerous lung tumours can help promote a stronger immune response. Additionally, they observed that this therapy helped to establish a long-lasting immune response against the cancer.

Engineering 130

Engineering Therapies Immune Response Treatment 130

Drug Discovery World

MARCH 4, 2024

In an early phase clinical trial, a combination of antibody-based medications targeting the immune system generated promising safety data and anti-tumour activity in individuals with advanced cancer. Both medications tested in the trial support immune responses against tumour cells.

Therapies 289

Therapies Immune Response Clinical Trials Trials 289

Drug Discovery World

FEBRUARY 19, 2024

At all assessed doses, RBI-4000 was well-tolerated and achieved a strong immune response, with protective virus-neutralising antibody titers above the World Health Organization (WHO)-defined immune surrogate level of protection against the rabies virus.

Vaccine 130

Vaccine Immune Response RNA Virus 130

Drug Discovery World

JULY 12, 2023

However, drugs that reduce inflammation by suppressing the whole immune response also inhibit the immune cells which promote repair. The University of Edinburgh-led study tested multiple drugs in zebrafish larvae for their ability to prevent excessive inflammation during an immune response.

Immune Response 130

Immune Response Drugs Regulations Treatment 130

Drugs.com

APRIL 12, 2024

FRIDAY, April 12, 2024 -- A chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI).There There is currently no vaccine for chlamydia, which.

Vaccine 116

Vaccine Trials Immune Response 116

Drug Discovery World

JANUARY 12, 2024

Researchers in the US have discovered that a type of immune cell in the human body known to be important for allergy and other immune responses can also attack cancer.

Research 289

Research Immune Response Virus Therapies 289

Drug Discovery World

AUGUST 3, 2023

The vaccine demonstrated a strong immune response, and the most common side effects were mild, and self-resolved within a few days of vaccination. Decisions on which Covid-19 vaccines are deployed in the UK are taken by the Joint Committee on Vaccination and Immunisation (JCVI).

Vaccine 130

Vaccine Immune Response Clinical Trials Virus 130

Broad Institute

MARCH 20, 2024

doi: 10.1038/s41590-024-01792-2 (2024) Scientists used a microscope to visualize an immunity hub (yellow and green) in human lung tumor tissue (blue). Networks of cells are critical in mediating immune responses. How do immune cells organize within tumors to effectively eliminate cancer cells? Nature Immunology.

Immune Response 128

Immune Response Hospitals Research Treatment 128

Drug Discovery World

AUGUST 16, 2022

Known as a bivalent vaccine, Spikevax was approved following data that show it triggers a strong immune response against both Omicron (BA.1) The booster dose was also found to generate a good immune response against the Omicron sub-variants BA.4 1) and the original 2020 strain 1. . ” .

Immune Response 130

Immune Response Vaccine Clinical Trials Virus 130

DrugBank

JULY 18, 2024

Adjuvants are substances added to vaccines to enhance the immune response. They work by decreasing the solubility of the vaccine, which sustains the release of the drug and prolongs the immune response. Even after a vaccine is approved and distributed, the pharmaceutical industry's responsibility does not end.

Vaccine 78

Vaccine Immune Response Clinical Trials Virus 78

Drugs.com

APRIL 16, 2024

TUESDAY, April 16, 2024 -- The nose appears to know when it comes to why children typically have milder cases of COVID-19 than seniors, a new study finds.Cells lining the inside of the nose are more likely to have a prompt immune response to COVID.

Immune Response 98

Immune Response 98

Science Daily: Pharmacology News

APRIL 29, 2024

The first study of the use of microarray patches to vaccinate children has shown that the method is safe and induces strong immune responses.

Vaccine 113

Vaccine Trials Immune Response 113

Drug Discovery World

MAY 28, 2024

Professor Trent Woodruff from UQ’s School of Biomedical Sciences said the new approach addressed an underlying cause of organ failure, while previous unsuccessful attempts had focused largely on the immune response.

Immune Response 147

Immune Response Hospitals Drugs Clinical Trials 147

SCIENMAG: Medicine & Health

FEBRUARY 2, 2024

Some hereditary genetic defects cause an exaggerated immune response that can be fatal. Using the CRISPR-Cas9 gene-editing tool, such defects can be corrected, thus normalizing the immune response, as researchers led by Klaus Rajewsky from the Max Delbrück Center now report in “Science Immunology.” Credit: Elijah D.

Immune Response 79

Immune Response Science Research 79

Drug Discovery World

SEPTEMBER 15, 2023

Replicate’s srRNA technology offers the potential for more robust and durable immune responses, and improved tolerability at lower doses than existing mRNA approaches,” said Zelanna Goldberg, CMO of Replicate. “In The Phase I trial will evaluate the safety, tolerability, and immunogenicity of RBI-4000 in 84 participants in the US.

Vaccine 130

Vaccine Trials Immune Response Virus 130

Drug Discovery World

FEBRUARY 20, 2024

Licensing for human use Adjuvants are components of vaccines that help to enhance the magnitude, breadth, and duration of the immune response to vaccination.

Vaccine 130

Vaccine Immune Response Licensing Licensing 130

Drug Discovery World

MARCH 8, 2024

Earlier this year, Alamar launched the ARGO HT System and the NULISAseq Inflammation Panel 250 for deep profiling of immune response. In July 2022 the company announced a partnership with Abcam to further their understanding of the human proteome.

Immune Response 130

Immune Response Marketing Research Drugs 130

Broad Institute

JULY 11, 2024

Treatment with mIDH1 blockers unearths these remnants, triggering an immune response against the tumor cells. This immune response relies on the expression of a gene called cGAS , which produces part of a protein that detects retroviruses.

Treatment 67

Treatment Immune Response Virus Drugs 67

Drug Discovery World

DECEMBER 16, 2022

STC-15 triggers both direct cytotoxic and immune response-based efficacy mechanisms in solid tumour and leukaemia models. Storm recently presented preclinical data at the 34th EORTC-NCI-AACR and SITC meetings, demonstrating blockade of METTL3 and effects on the innate immune response. . .

RNA 130

RNA Immune Response Small Molecule Therapies 130

SugarCone Biotech

JUNE 10, 2024

Targeting 4-1BB remained of interest to the immuno-oncology field as cell culture experiments and tumor models in mice suggested that robust anti-tumor immune responses could be triggered by anti-4-1BB antibody therapies. This is the T cell type most closely associated with anti-tumor immune responses. One more question.

Immune Response 88

Immune Response Regulations Production Clinical Trials 88

Drugs.com

SEPTEMBER 14, 2023

14, 2023 -- An oral vaccine for COVID-19 appears to produce the sort of immune response that could quickly stamp out a developing infection, according to results from a small-scale primate study. THURSDAY, Sept. Some monkeys given an experimental.

Vaccine 119

Vaccine Immune Response 119

Drugs.com

OCTOBER 11, 2023

The phase 1 clinical trial showed that the product, administered nasally in two doses, delivered a significant immune response to. WEDNESDAY, Oct. 11, 2023 -- New research points to the potential of a COVID-19 vaccine delivered through the nose.

Vaccine 114

Vaccine Trials Immune Response Clinical Trials 114